Monitoring of RAS mutant clones in plasma of patients with RAS mutant metastatic colorectal cancer

PURPOSE: Some patients with histologically confirmed primary mCRC and mutated RAS reported undetectable RAS mutant clones in plasma after receiving anti-VEGF treatment. The aim was to prospectively assess it with its potential therapeutic implications. METHODS: RAS mutant genes in solid biopsy (befo...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández Montes, A., Élez, E., Vivancos, A., Martínez, N., González, P., Covela, M., de la Cámara, J., Cousillas, A., Méndez, J. C., Graña, B., Aranda, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Brief Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107427/
https://www.ncbi.nlm.nih.gov/pubmed/34997474
http://dx.doi.org/10.1007/s12094-021-02767-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107427/
https://www.ncbi.nlm.nih.gov/pubmed/34997474
http://dx.doi.org/10.1007/s12094-021-02767-7

Ejemplares similares